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Celiac disease is an autoimmune systemic disorder. It presents gastrointestinal and nongastrointestinal manifestations as well
as associated conditions. We report a 16-year-old Down syndrome girl who presented psychosis symptomatology, and she was
diagnosed as having silent celiac disease. Olanzapine treatment and gluten-free diet were satisfactory. It is necessary to consider
celiac disease in Down syndrome patients with psychiatric symptoms, mainly psychotic symptomatology.
1.Introduction
Celiac disease (CD) is an autoimmune systemic disorder
caused by a gluten permanent intolerance. CD mainly aﬀects
thedigestivetract,butnotexclusively,becauseitalsopresents
nongastrointestinal manifestations and associated condi-
tions, which are unlikely to show accompanying digestive
symptoms; then it is called silent CD [1, 2].
Down syndrome is one of these associated conditions
because it presents an increase of autoimmune diseases
frequency, especially CD and hypothyroidism [1, 3, 4].
On the other hand, CD has also been linked to various
neurological and neuropsychological manifestations [5, 6].
Among them is schizophrenia although its relationship with
CD is not fully established [7–10].
We report a 16-year-old Down syndrome girl diagnosed
as having silent CD while suﬀering psychotic symptoms.
2. Patient
A 16-year-old Down syndrome girl (trisomy 21) was referred
to our clinic reporting dizziness. Her family had noticed
changes in her behavior over the last few months: speaking
alone, sleep disturbances, irritability and emotional instabil-
ity, school work deterioration, and social withdrawal. There
was no ﬂuctuation in her conscious level. Toxic ingestion
matter was negative, and no digestive manifestations were
presented.
The physical examination showed a speciﬁc phenotype
and mild mental retardation. She was calm, collaborating
and answering some simple questions quietly. Her mental
state was apparently normal. She presented a minimal bi-
lateral intention tremor and dysdiadochokinesia.
A cerebral magnetic resonance imaging (MRI) revealed
a discreet atrophy of the cerebellar vermis. The electroen-
cephalogram (EEG) result was normal. Laboratory data
showed macrocytosis (mean corpuscular volume: 101 ﬂ [80–
99]) without anemia, and IgA hypergammaglobulinemia
level of 646mg/dL (70–400) and IgG level of 1306mg/dL
(700–1200). Vitamin B6 and folic acid were normal. T4 and
TSH were normal.
IgA gliadin antibodies were 38.1U/mL (positive >10),
and IgG gliadin antibodies were 16.7U/mL (positive >10).
IgA antibodies to tissue transglutaminase (anti-t-TG) were
230.5U/mL (positive >10). HLA-DQ2 phenotype was posi-
tive. Intestinal biopsy showed an atrophic duodenitis type 3B
Marsh classiﬁcation.
Treatment began with olanzapine (20mg/day) along
with gluten-free diet. Psychotic symptoms improved in two
months. Antibodies were negative a year later.
After two years of treatment, we proceeded to phase
out olanzapine over a 6-month period. Psychotic symptoms2 Case Reports in Pediatrics
(personality change, insomnia, and auditory hallucinations)
reappeared a month after drug treatment withdrawal, while
the patient kept gluten-freediet correctly.Antibodies contin-
ued to be negative too.
After restarting olanzapine treatment, psychotic symp-




We present a Down syndrome adolescent who developed
psychotic symptoms and was diagnosed as having silent CD.
Down syndrome presents a greater frequency of autoim-
mune diseases. CD prevalence in Down syndrome patients is
between 5 and 12 percent. Many studies recommend check-
ing up on CD in Down syndrome patients periodically, since
one-third of patients has non-gastrointestinal symptoms [1].
Psychiatric symptoms in Down syndrome patients are
varied, notably depression and early dementia from the
age of 40 on. Psychiatric problems diagnosis in these kind
of patients tends to be quite complicated, due to mental
retardation existence [11].
The relationship between CD and schizophrenia was ﬁrst
describedin1953byBender[12].Sincethen,therehavebeen
diﬀerentstudies,andvarioushypotheseshavebeensuggested
(cerebral hypoperfusion, intestinal malabsorption, disorders
of neurotransmitters metabolism, and autoimmune disease)
although the causal relationship between schizophrenia and
CD has not been established yet [6, 13].
A Down syndrome adolescent case with psychotic
symptoms and CD has never been published, despite the
relationship that exists between these three conditions. Only
Serratriceetal.[14]describeda42-year-oldDownsyndrome
woman who presented psychotic symptoms. She was under
treatment for a year with pharmacotherapy (haloperidol,
olanzapine) with no improvement. Later investigations
showed positive IgA and IgG gliadin antibodies, positive
HLA-DQ2, and normal intestinal biopsy. Then she was
diagnosed having silent CD, and she started with a gluten-
free diet. After a year with a gluten-free diet, together with
olanzapine treatment, the psychotic symptoms improved
clearly.
These authors emphasize three facts: the diﬃculty of
ad i ﬀerential diagnosis between psychotic symptomatology
and the onset of early dementia in Down syndrome patients,
the role of CD in psychiatric symptoms appearance, and the
improvement of psychotic symptoms with a gluten-free diet.
Their diagnosis was silent CD as even intestinal biopsy was
normal. Despite this fact, we believe that silent CD should
notbeconsideredinthesecases;itisbettertothinkofalatent
CD, and the role and the importance of gluten-free diet is
even more controversial.
In our case, the diagnosis was a silent CD because
antibodies were positive, HLA-DQ2 was positive, intestinal
biopsy was type 3B, and she has not gastrointestinal symp-
toms. The diﬀerential diagnosis with early dementia was not
considered due to patient age.
Our patient improved considerably with olanzapine
treatment together with gluten-free diet. Olanzapine with-
drawal was decided after two years of treatment, bearing in
mind that some patients with schizophrenia and CD had
improved only with the gluten-free diet [15]. In our case,
olanzapine treatment had to be reestablished. This is the
reason why we cannot establish a speciﬁc causal relationship
between CD and psychotic symptomatology.
In conclusion, CD has to be investigated in any Down
syndrome patient with psychiatric symptoms, especially
psychotic type symptoms, even when there are no gastroin-
testinal manifestations.
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